Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · ACCENDRA HEALTH INC/VA/ (ACH)

Accendra Health says COO Perry Bernocchi moves to strategic advisor role through Dec. 31, 2026

Neutral Impact 4 of 5 leadership Written later

Accendra Health's Executive Vice President and Chief Operating Officer, Perry Bernocchi, will cease to be an executive officer under a transition agreement dated October 29, 2026, and serve as Strategic Advisor to the CEO until December 31, 2026, unless his employment ends earlier. He keeps his current base salary and remains eligible for his 2026 annual bonus at target and for applicable severance, which matters to shareholders as a senior operating leadership change.

Key points

  • Perry A. Bernocchi, EVP and Chief Operating Officer, ceases to be an executive officer under agreement dated October 29, 2026
  • Serves as Strategic Advisor to the Chief Executive Officer until December 31, 2026, unless employment ends earlier
  • Keeps current base salary and remains eligible for 2026 annual bonus at current target
  • Remains eligible for severance under Officer Severance Policy or change of control agreement, as applicable

The filing

CompanyACCENDRA HEALTH INC/VA/ (ACH)
Form8-K, current report
Filed with the SECNov 3, 2026, 4:41 PM ET
Accession number0001104659-26-122072

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:51 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 03, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.